Neurotrigger develops a system designed to improve the functioning of patients suffering from facial nerve paralysis and other diseases.
Neurotrigger has raised $520K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2025.
Neurotrigger is headquartered in Tel Aviv, Israel.
Neurotrigger develops a system designed to improve the functioning of patients suffering from facial nerve paralysis and other diseases.
Neurotrigger is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Neurotrigger — Funding & Investors." VCBacked, April 22, 2025, https://www.vcbacked.co/company/neurotrigger. Accessed July 20, 2026.
VCBacked. (2025). Neurotrigger — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/neurotrigger
{{cite web |title=Neurotrigger — Funding & Investors |url=https://www.vcbacked.co/company/neurotrigger |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated